ACHC

Acadia Healthcare Company, Inc. NASDAQ

Healthcare ·Medical - Care Facilities ·US · acadiahealthcare.com

$27.68

Mkt Cap $2.5B

52w Low $11.43 86.6% of range 52w High $30.20

50d MA $24.51 200d MA $20.34

P/E (TTM) -2.3x

EV/EBITDA -5.2x

P/B 1.2x

Debt/Equity 1.4x

ROE -56.6%

P/FCF -2.9x

RSI (14) —

ATR (14) —

Beta 0.71

50d MA $24.51

200d MA $20.34

Avg Volume 3.4M

About

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 29, 2026	AMC	0.28	0.37	+32.1%	28.26	-4.0%	-8.4%	-1.5%	-2.0%	—	—	—
Feb 25, 2026	AMC	0.03	0.07	+133.3%	20.84	+1.8%	+7.0%	+12.5%	+12.5%	+10.3%	+15.5%	—
Nov 5, 2025	AMC	0.68	0.72	+5.9%	20.68	-8.1%	-2.0%	-5.7%	-12.1%	-11.8%	-15.8%	—
Aug 5, 2025	AMC	0.71	0.83	+16.9%	21.76	-4.5%	-17.3%	-16.4%	-11.6%	-12.4%	-6.6%	—
May 12, 2025	AMC	0.35	0.40	+14.3%	25.84	+1.6%	+4.3%	-0.5%	-0.8%	+1.2%	-2.9%	—
Feb 27, 2025	AMC	0.75	0.64	-14.7%	40.26	-19.3%	-25.5%	-27.3%	-24.3%	-26.3%	-25.7%	—
Oct 30, 2024	AMC	0.90	0.91	+1.1%	52.08	-12.6%	-18.0%	-19.3%	-18.7%	-18.4%	-18.4%	—
Jul 31, 2024	AMC	0.87	0.91	+4.6%	64.85	+6.8%	+14.2%	+11.6%	+9.5%	+9.4%	+9.1%	—
May 1, 2024	AMC	0.81	0.84	+3.7%	72.99	-3.9%	-8.6%	-9.4%	-7.1%	-7.6%	-9.5%	—
Feb 27, 2024	AMC	0.80	0.85	+6.2%	87.38	-0.8%	-4.5%	-4.5%	-3.9%	-2.0%	-3.0%	—
Nov 2, 2023	AMC	0.88	0.91	+3.4%	73.24	+2.6%	-1.4%	+0.4%	+1.4%	+0.6%	-1.4%	—
Jul 27, 2023	AMC	0.86	0.92	+7.0%	73.36	+6.2%	+8.3%	+7.7%	+7.0%	+7.4%	+5.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 4	Raymond James	Upgrade	Outperform → Strong Buy	$39	$27.85	$29.38	+5.5%	-0.6%	—	—	—	—
May 1	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$25.90	$25.79	-0.4%	+7.5%	—	—	—	—
May 1	Barclays	Maintains	Equal Weight → Equal Weight	—	$25.90	$25.79	-0.4%	+7.5%	—	—	—	—
Apr 28	TD Cowen	Maintains	Buy → Buy	—	$28.15	$28.42	+1.0%	-2.0%	+0.4%	-8.0%	-1.1%	—
Apr 17	UBS	Maintains	Buy → Buy	—	$26.89	$27.00	+0.4%	+0.4%	+3.5%	+2.0%	+4.2%	+1.7%
Mar 3	Barclays	Maintains	Equal Weight → Equal Weight	—	$23.44	$22.84	-2.6%	-1.9%	+2.7%	+5.2%	+9.3%	+5.4%
Feb 26	RBC Capital	Maintains	Outperform → Outperform	—	$20.84	$21.22	+1.8%	+7.0%	+12.5%	+12.5%	+10.3%	+15.5%
Feb 26	UBS	Maintains	Buy → Buy	—	$20.84	$21.22	+1.8%	+7.0%	+12.5%	+12.5%	+10.3%	+15.5%
Feb 26	Leerink Partners	Maintains	Market Perform → Market Perform	—	$20.84	$21.22	+1.8%	+7.0%	+12.5%	+12.5%	+10.3%	+15.5%
Feb 26	TD Cowen	Maintains	Buy → Buy	—	$20.84	$21.22	+1.8%	+7.0%	+12.5%	+12.5%	+10.3%	+15.5%
Feb 23	Guggenheim	Maintains	Buy → Buy	—	$16.79	$16.65	-0.8%	+3.5%	+2.3%	+24.1%	+32.8%	+39.6%
Jan 22	Jefferies	Downgrade	Buy → Hold	—	$14.33	$13.85	-3.3%	+5.7%	+6.3%	+6.3%	-5.9%	-6.2%
Jan 16	TD Cowen	Maintains	Buy → Buy	—	$11.91	$11.86	-0.4%	-1.9%	+19.6%	+20.3%	+27.2%	+27.9%
Jan 14	RBC Capital	Maintains	Outperform → Outperform	—	$12.55	$12.49	-0.5%	-6.5%	-5.1%	-6.9%	+13.5%	+14.2%
Dec 18	Mizuho	Maintains	Neutral → Neutral	—	$14.53	$14.48	-0.3%	-0.7%	-0.8%	-0.5%	-3.0%	-1.6%
Dec 4	Barclays	Maintains	Equal Weight → Equal Weight	—	$14.69	$14.73	+0.3%	-0.3%	+5.3%	-4.7%	-4.6%	-6.4%
Dec 3	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$16.49	$12.89	-21.8%	-10.9%	-11.2%	-6.2%	-15.1%	-15.0%
Dec 3	Deutsche Bank	Maintains	Buy → Buy	—	$16.49	$12.89	-21.8%	-10.9%	-11.2%	-6.2%	-15.1%	-15.0%
Dec 3	UBS	Maintains	Buy → Buy	—	$16.49	$12.89	-21.8%	-10.9%	-11.2%	-6.2%	-15.1%	-15.0%
Dec 3	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$16.49	$12.89	-21.8%	-10.9%	-11.2%	-6.2%	-15.1%	-15.0%
Dec 3	BofA Securities	Downgrade	Neutral → Underperform	—	$16.49	$12.89	-21.8%	-10.9%	-11.2%	-6.2%	-15.1%	-15.0%
Dec 3	Leerink Partners	Downgrade	Outperform → Market Perform	—	$16.49	$12.89	-21.8%	-10.9%	-11.2%	-6.2%	-15.1%	-15.0%
Dec 3	RBC Capital	Maintains	Outperform → Outperform	—	$16.49	$12.89	-21.8%	-10.9%	-11.2%	-6.2%	-15.1%	-15.0%
Nov 18	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$15.65	$15.65	+0.0%	-4.1%	-8.4%	-8.2%	-3.0%	-0.7%
Nov 12	RBC Capital	Maintains	Outperform → Outperform	—	$18.24	$18.20	-0.2%	-4.6%	-11.8%	-12.2%	-14.2%	-17.7%
Nov 10	Guggenheim	Maintains	Buy → Buy	—	$19.51	$19.19	-1.6%	-6.9%	-6.5%	-10.8%	-17.6%	-17.9%
Nov 7	UBS	Maintains	Buy → Buy	—	$20.26	$19.75	-2.5%	-3.7%	-10.3%	-10.0%	-14.1%	-20.6%
Nov 7	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$20.26	$19.75	-2.5%	-3.7%	-10.3%	-10.0%	-14.1%	-20.6%
Nov 6	Barclays	Maintains	Equal Weight → Equal Weight	—	$20.68	$19.00	-8.1%	-2.0%	-5.7%	-12.1%	-11.8%	-15.8%
Oct 8	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$27.23	$26.74	-1.8%	-6.0%	-7.5%	-10.9%	-10.8%	-8.4%
Oct 7	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$26.46	$26.70	+0.9%	+2.9%	-3.3%	-4.8%	-8.3%	-8.2%
Oct 3	Raymond James	Maintains	Outperform → Outperform	—	$26.62	$26.53	-0.3%	+2.0%	-0.6%	+2.3%	-3.8%	-5.4%
Sep 10	BofA Securities	Downgrade	Buy → Neutral	—	$23.30	$22.64	-2.8%	-9.6%	-4.2%	-6.7%	-8.1%	-6.8%
Aug 14	Raymond James	Downgrade	Strong Buy → Outperform	—	$20.77	$19.92	-4.1%	-0.5%	+1.0%	+1.7%	+3.9%	+2.6%
Aug 14	Mizuho	Maintains	Neutral → Neutral	—	$20.77	$19.92	-4.1%	-0.5%	+1.0%	+1.7%	+3.9%	+2.6%
Aug 13	RBC Capital	Maintains	Outperform → Outperform	—	$20.33	$20.25	-0.4%	+2.2%	+1.6%	+3.2%	+3.9%	+6.2%
Aug 7	Guggenheim	Maintains	Buy → Buy	—	$18.00	$18.17	+0.9%	+1.1%	+6.9%	+5.9%	+12.9%	+15.4%
Aug 7	Barclays	Maintains	Equal Weight → Equal Weight	—	$18.00	$18.17	+0.9%	+1.1%	+6.9%	+5.9%	+12.9%	+15.4%
Aug 7	UBS	Maintains	Buy → Buy	—	$18.00	$18.17	+0.9%	+1.1%	+6.9%	+5.9%	+12.9%	+15.4%
Aug 7	TD Cowen	Maintains	Buy → Buy	—	$18.00	$18.17	+0.9%	+1.1%	+6.9%	+5.9%	+12.9%	+15.4%
May 14	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$26.94	$27.00	+0.2%	-4.5%	-4.8%	-2.9%	-6.9%	-6.5%
May 14	Mizuho	Maintains	Neutral → Neutral	—	$26.94	$27.00	+0.2%	-4.5%	-4.8%	-2.9%	-6.9%	-6.5%
May 14	Barclays	Maintains	Equal Weight → Equal Weight	—	$26.94	$27.00	+0.2%	-4.5%	-4.8%	-2.9%	-6.9%	-6.5%
May 13	BofA Securities	Maintains	Buy → Buy	—	$25.84	$26.26	+1.6%	+4.3%	-0.5%	-0.8%	+1.2%	-2.9%
Apr 3	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$29.21	$28.70	-1.7%	-2.8%	-6.3%	-9.6%	-7.2%	-0.4%
Mar 25	Mizuho	Maintains	Neutral → Neutral	—	$28.94	$29.06	+0.4%	-0.4%	+2.5%	+4.1%	+4.1%	+4.8%
Mar 3	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$29.98	$30.46	+1.6%	-2.4%	+1.6%	-1.0%	-0.2%	+2.0%
Mar 3	RBC Capital	Maintains	Outperform → Outperform	—	$29.98	$30.46	+1.6%	-2.4%	+1.6%	-1.0%	-0.2%	+2.0%
Feb 28	Barclays	Downgrade	Overweight → Equal Weight	—	$40.26	$32.50	-19.3%	-25.5%	-27.3%	-24.3%	-26.3%	-25.7%
Feb 28	BofA Securities	Maintains	Buy → Buy	—	$40.26	$32.50	-19.3%	-25.5%	-27.3%	-24.3%	-26.3%	-25.7%

Recent Filings

8-K · 7.01 ! Medium

Acadia Healthcare Company, Inc. -- 8-K 7.01: Regulation FD Disclosure

Acadia Healthcare announced a Chief Financial Officer transition on April 23, 2026, signaling potential strategic shifts in financial management and company direction.

Apr 23

8-K · 7.01 ! Medium

Unknown — 8-K 7.01: Regulation FD Disclosure

Without seeing the actual press release content, I cannot provide specific analysis; however, investors should review Exhibit 99.1 immediately to assess whether disclosed matters affect earnings guidance, operations, or competitive positioning.

Mar 12

8-K · 7.01 ! Medium

Acadia Healthcare Company, Inc. -- 8-K 7.01: Regulation FD Disclosure

Acadia Healthcare will host a February 25, 2026 earnings call to discuss fourth-quarter 2025 results, with presentation slides available for investor reference.

Feb 25

Data updated apr 24, 2026 10:31am · Source: massive.com